Expert opinion on drug safety
Sex differences in thyroid dysfunction onset timing induced by immune checkpoint inhibitors: JADER disproportionality analysis.
Naohito Ide, Yuki Tsuruta, Ken-Ichi Sako, Tomoji Maeda
Published: 202610.1080/14740338.2026.2618292
Abstract
BACKGROUND: Immune checkpoint inhibitors (ICIs) are widely used in cancer treatment but can induce thyroid dysfunction. While the incidence of ICI-induced thyroid dysfunction (ICI-TD) has been studied, the timing of onset, particularly in relation to…
Preview only. Read the full abstract at the source